SCHEMBL10114537

SCHEMBL10114537

CC(=O)Oc1ccc(C(=O)Nc2ncc(S(C)(=O)=O)s2)c(C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.41
HSD17B10 Q99714 2/20 0.41
NPC1 O15118 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 3/20 0.41
STAT3 P40763 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MLNR O43193 1/20 0.41
NR1I2 O75469 1/20 0.41
ABCB11 O95342 1/20 0.41
TP53 P04637 1/20 0.41
ADRB2 P07550 1/20 0.41
CHRM2 P08172 1/20 0.41
ADRB1 P08588 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADRA2A P08913 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10114555 0.88 FFAR2 (0.44) RAB9AHSD17B10NPC1SMN1; SMN2ALDH1A1
SCHEMBL702024 0.85 RAB9A (0.57) RAB9AHSD17B10NPC1SMN1; SMN2ALDH1A1
SCHEMBL4757157 0.84 STAT3 (0.49) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL4757105 0.83 FFAR2 (0.44) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL4756608 0.83 ALDH1A1 (0.41) RAB9AHSD17B10NPC1SMN1; SMN2ALDH1A1
SCHEMBL703471 0.81 MEN1 (0.51) RAB9ANPC1SMN1; SMN2ALDH1A1MEN1
SCHEMBL13907036 0.81 RAB9A (0.42) RAB9AHSD17B10NPC1SMN1; SMN2ALDH1A1
SCHEMBL4755812 0.80 ALDH1A1 (0.46) RAB9AHSD17B10NPC1SMN1; SMN2ALDH1A1
SCHEMBL4756645 0.79 NPC1 (0.41) RAB9AHSD17B10NPC1SMN1; SMN2ALDH1A1
SCHEMBL4756653 0.79 POLB (0.40) RAB9AHSD17B10NPC1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2178852-B9 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2016-06-22 EP disclosed
EP-2178852-B1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2015-07-22 EP disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC RAB9A 1694/4885HSD17B10 921/4885NPC1 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.